MCID: MXD026
MIFTS: 36

Mixed Glioma

Categories: Cancer diseases, Neuronal diseases

Aliases & Classifications for Mixed Glioma

MalaCards integrated aliases for Mixed Glioma:

Name: Mixed Glioma 12 55 15
Mixed Gliomas 12 72
Mixed Neuroglial Tumor 12
Glioma 72

Classifications:



External Ids:

Disease Ontology 12 DOID:5076
MeSH 44 D005910
NCIt 50 C3903
SNOMED-CT 68 22217002
UMLS 72 C0017638 C0259783

Summaries for Mixed Glioma

MalaCards based summary : Mixed Glioma, also known as mixed gliomas, is related to pilocytic astrocytoma and glioma. An important gene associated with Mixed Glioma is GFAP (Glial Fibrillary Acidic Protein), and among its related pathways/superpathways are Photodynamic therapy-induced AP-1 survival signaling. and Central carbon metabolism in cancer. The drugs Midazolam and Trametinib have been mentioned in the context of this disorder. Affiliated tissues include brain, t cells and testes.

Related Diseases for Mixed Glioma

Diseases related to Mixed Glioma via text searches within MalaCards or GeneCards Suite gene sharing:

(show top 50) (show all 89)
# Related Disease Score Top Affiliating Genes
1 pilocytic astrocytoma 29.9 IDH1 GFAP
2 glioma 29.8 TP53 PDGFRA IDH1
3 juvenile pilocytic astrocytoma 29.6 TP53 GFAP
4 glioblastoma 29.1 TP53 PDGFRA IDH1
5 oligodendroglioma 29.0 TP53 PDGFRA IDH1 GFAP
6 glioma susceptibility 1 28.9 TP53 IDH1 GFAP
7 gliomatosis cerebri 28.9 TP53 IDH1 GFAP
8 glioblastoma multiforme 28.6 TP53 PDGFRA IDH1 GFAP
9 adult brainstem mixed glioma 12.4
10 oligoastrocytoma 11.7
11 mixed oligodendroglioma-astrocytoma 11.6
12 anaplastic oligoastrocytoma 11.6
13 glial tumor 10.4
14 ileum cancer 10.3 PDGFRA GFAP
15 neurilemmoma 10.2 PDGFRA GFAP
16 extraventricular neurocytoma 10.2 IDH1 GFAP
17 dysembryoplastic neuroepithelial tumor 10.2 IDH1 GFAP
18 angiocentric glioma 10.2 IDH1 GFAP
19 childhood oligodendroglioma 10.2 IDH1 GFAP
20 astrocytoma 10.2
21 undifferentiated pleomorphic sarcoma 10.2 PDGFRA IDH1
22 cerebellopontine angle tumor 10.1 IDH1 GFAP
23 frontal convexity meningioma 10.1 TP53 GFAP
24 gliofibroma 10.1 TP53 GFAP
25 cerebral convexity meningioma 10.0 TP53 GFAP
26 protoplasmic astrocytoma 10.0 TP53 GFAP
27 cellular ependymoma 10.0 TP53 GFAP
28 meninges sarcoma 10.0 TP53 GFAP
29 central nervous system primitive neuroectodermal neoplasm 10.0 TP53 GFAP
30 spinal cancer 10.0 TP53 GFAP
31 cerebral neuroblastoma 10.0 TP53 GFAP
32 ependymoblastoma 10.0 TP53 GFAP
33 chordoid glioma 10.0 TP53 GFAP
34 cerebral ventricle cancer 10.0 TP53 GFAP
35 malignant ependymoma 10.0 TP53 GFAP
36 papilloma of choroid plexus 10.0 TP53 GFAP
37 choroid plexus cancer 10.0 TP53 GFAP
38 cystic teratoma 10.0 TP53 GFAP
39 teratoma 10.0 TP53 GFAP
40 necrotizing sialometaplasia 10.0 TP53 GFAP
41 cerebellar liponeurocytoma 10.0 TP53 GFAP
42 central nervous system benign neoplasm 10.0 TP53 GFAP
43 medullomyoblastoma 9.9 TP53 GFAP
44 anaplastic oligodendroglioma 9.9
45 optic nerve glioma 9.9 TP53 GFAP
46 infratentorial cancer 9.9 TP53 GFAP
47 ganglioglioma 9.9 TP53 GFAP
48 breast malignant phyllodes tumor 9.9 TP53 AGO2
49 atypical teratoid rhabdoid tumor 9.8 TP53 GFAP
50 intracranial chondrosarcoma 9.8 TP53 IDH1

Graphical network of the top 20 diseases related to Mixed Glioma:



Diseases related to Mixed Glioma

Symptoms & Phenotypes for Mixed Glioma

Drugs & Therapeutics for Mixed Glioma

Drugs for Mixed Glioma (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 585)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Midazolam Approved, Illicit Phase 4 59467-70-8 4192
2
Trametinib Approved Phase 4 871700-17-3 11707110
3
Dabrafenib Approved, Investigational Phase 4 1195765-45-7 44462760 44516822
4
Glutamic acid Approved, Nutraceutical Phase 4 56-86-0 33032
5 Anti-Anxiety Agents Phase 4
6 Neurotransmitter Agents Phase 4
7 Excitatory Amino Acid Antagonists Phase 4
8 Excitatory Amino Acids Phase 4
9 alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid Phase 4
10 Excitatory Amino Acid Agonists Phase 4
11
Lenograstim Approved, Investigational Phase 3 135968-09-1
12
Thiotepa Approved, Investigational Phase 3 52-24-4 5453
13
Dextroamphetamine Approved, Illicit Phase 3 51-64-9 5826
14
Donepezil Approved Phase 3 120014-06-4 3152
15
Heparin Approved, Investigational Phase 3 9005-49-6 46507594 772
16
Dalteparin Approved Phase 3 9005-49-6
17
Somatostatin Approved, Investigational Phase 2, Phase 3 38916-34-6, 51110-01-1 53481605
18
Fentanyl Approved, Illicit, Investigational, Vet_approved Phase 3 437-38-7 3345
19
Thioguanine Approved Phase 3 154-42-7 2723601
20
Valproic acid Approved, Investigational Phase 3 99-66-1 3121
21
chloroquine Approved, Investigational, Vet_approved Phase 3 54-05-7 2719
22
Ethanol Approved Phase 2, Phase 3 64-17-5 702
23
Disulfiram Approved Phase 2, Phase 3 97-77-8 3117
24
Copper Approved, Investigational Phase 2, Phase 3 7440-50-8 27099
25
Lomustine Approved, Investigational Phase 3 13010-47-4 3950
26
Irinotecan Approved, Investigational Phase 3 100286-90-6, 97682-44-5 60838
27
Etoposide Approved Phase 3 33419-42-0 36462
28
Cyclophosphamide Approved, Investigational Phase 3 50-18-0, 6055-19-2 2907
29
Doxorubicin Approved, Investigational Phase 3 23214-92-8 31703
30
leucovorin Approved Phase 3 58-05-9 143 6006
31
Vincristine Approved, Investigational Phase 3 57-22-7, 2068-78-2 5978
32
Dopamine Approved Phase 3 51-61-6, 62-31-7 681
33
Methylphenidate Approved, Investigational Phase 3 113-45-1 4158
34
Histamine Approved, Investigational Phase 3 51-45-6 774
35
Methotrexate Approved Phase 3 1959-05-2, 59-05-2 126941
36
Cyproheptadine Approved Phase 3 129-03-3 2913
37
Norepinephrine Approved Phase 3 51-41-2 439260
38
Dactinomycin Approved, Investigational Phase 3 50-76-0 457193 2019
39
Ornithine Approved, Nutraceutical Phase 3 70-26-8, 3184-13-2 6262
40
Folic acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
41 Pancreatic Polypeptide Investigational Phase 3 59763-91-6
42 Dianhydrogalactitol Investigational Phase 3 23261-20-3
43 Analgesics, Non-Narcotic Phase 3
44 Anti-Inflammatory Agents, Non-Steroidal Phase 3
45 Emetics Phase 3
46 Anesthetics, Inhalation Phase 3
47 Cholinesterase Inhibitors Phase 3
48 Heparin, Low-Molecular-Weight Phase 3
49 calcium heparin Phase 3
50 Endothelial Growth Factors Phase 2, Phase 3

Interventional clinical trials:

(show top 50) (show all 1349)
# Name Status NCT ID Phase Drugs
1 A Prospective, Single-Blinded, Randomized Study of Awake vs Intubated General Anesthesia in Patients Undergoing Elective Craniotomy for Supratentorial Glioma Resection Completed NCT02193568 Phase 4
2 Phase II Feasibility Study to Evaluate the Efficacy and Safety of Perampanel in Seizure Patients With Primary Glial Brain Tumors Completed NCT02363933 Phase 4 Perampanel
3 Seizure Treatment IN Glioma (STING): Comparing a Treatment Strategy With Levetiracetam Versus Treatment With Valproic Acid in Glioma Patients With a First Seizure Recruiting NCT03048084 Phase 4 Levetiracetam;Valproic Acid
4 Open Label, Multi-center Roll-over Study to Assess Long Term Safety in Patients Who Have Completed a Global Novartis or GSK Sponsored Dabrafenib and/or Trametinib Study Recruiting NCT03340506 Phase 4 dabrafenib;trametinib
5 An Open Label, Multi-center Roll-over Study to Assess Long-term Effect in Pediatric Patients Treated With Tafinlar (Dabrafenib) and/or Mekinist (Trametinib) Not yet recruiting NCT03975829 Phase 4 dabrafenib;trametinib
6 A Study of CIK in Combination With Temozolomide With and Without Radiation in Adults With Advanced Malignant Gliomas Not yet recruiting NCT02496988 Phase 4 Temozolomide
7 Cognitive Rehabilitation of Glioma Patients: a Prospective, Randomized Study Unknown status NCT00256425 Phase 3
8 Impact of Surgery on the Treatment of Supratentorial Malignant Gliomas in Subjects Aged 70 and Over Unknown status NCT02892708 Phase 3
9 Prospective Randomized Trial of Two Hypofractionated Radiotherapy Regimens Versus Conventional Radiotherapy in Pediatric Diffuse Brainstem Glioma Unknown status NCT01878266 Phase 3
10 Phase 3 Study of Carmustine Sustained Release Implant (CASANT) to Treat Newly Diagnosed Malignant Glioma Unknown status NCT01656980 Phase 3 Carmustine
11 A Study Evaluating Dexamfetamine Sulphate in Patients With Glioma Suffering From Severe Asthenia. A Phase III Double-blind Randomized Placebo-controlled Trial Unknown status NCT02363075 Phase 3 Dexamfetamine sulphate;placebo
12 Ultimate Low Grade Glioma Study Unknown status NCT00003015 Phase 3 carboplatin;vincristine sulfate
13 Barrow 5-ALA Intraoperative Confocal Evaluation Trial Unknown status NCT01502280 Phase 3 5-Aminolevulinic acid (ALA);Placebo - ascorbic acid
14 A Prospective, Randomized, Controlled, Double-blind, Multi-center Clinical Study of Nimotuzumab Combinated With Gemcitabine Contrast to Placebo Combinated With Gemcitabine in K-RAS Wild-type,Locally Advanced and Metastatic Pancreatic Cancer Unknown status NCT02395016 Phase 3 nimotuzumab;Gemcitabine
15 Treatment of Children and Adolescents With Diffuse Intrinsic Pontine Glioma and High Grade Glioma Unknown status NCT00278278 Phase 3 cisplatin;etoposide;ifosfamide;lomustine;methotrexate;prednisone;vincristine sulfate
16 A Phase III Clinical Trial Evaluating DCVax®-L, Autologous Dendritic Cells Pulsed With Tumor Lysate Antigen For The Treatment Of Glioblastoma Multiforme (GBM) Unknown status NCT00045968 Phase 3 Dendritic cell immunotherapy
17 A Prospective,Randomized,Double-Blind,Controlled,Multicenter,Phase III Study of Nimotuzumab in Combination With Chemotherapy and Radiotherapy for Patients With Local Advanced Nasopharyngeal Cancer Unknown status NCT01074021 Phase 3 Nimotuzumab;placebo plus chemoradiotherapy
18 Dose Intensive Chemotherapy for Children Less Than Ten Years of Age Newly-Diagnosed With Malignant Brain Tumors: A Pilot Study of Two Alternative Intensive Induction Chemotherapy Regimens, Followed by Consolidation With Myeloablative Chemotherapy (Thiotepa and Carboplatin, With or Without Etoposide) and Autologous Stem Cell Rescue [HEAD START III] Unknown status NCT00392886 Phase 3 carboplatin;cisplatin;cyclophosphamide;etoposide;methotrexate;temozolomide;thiotepa;vincristine sulfate
19 A Phase III Randomized Study (Phase I Closed) of Radiation Therapy and Temozolomide Versus Radiation Therapy and Nitrosourea for Anaplastic Astrocytoma And Mixed Anaplastic Oligoastrocytoma (Astrocytoma Dominant) Completed NCT00004259 Phase 3 BCNU 80mg/m2;TMZ 200mg/m2;CCNU;BCNU 150mg/m2;BCNU 200mg/m2;TMZ 150mg/m2 six 6-week cycles;TMZ 150mg/m2 six 8-week cycles
20 A Randomized Prospective Two Arm Clinical Trial of High Light Dose And Low Light Dose PDT in the Treatment of Recurrent Malignant Supratentorial Gliomas Using Porfimer Sodium [Photofrin] Completed NCT00118222 Phase 3 porfimer sodium
21 Primary Chemotherapy With Temozolomide Versus Radiotherapy in Patients With Low Grade Gliomas After Stratification for Genetic 1p Loss: A Phase III Study Completed NCT00182819 Phase 3 temozolomide
22 Phase III Double Blind, Placebo Controlled Study of Donepezil in the Irradiated Brain Completed NCT00369785 Phase 3 donepezil hydrochloride;Placebo
23 Randomized Controlled Trial of Acupressure to Control Chemotherapy-Induced Nausea (CIN) in Children Receiving Highly Emetogenic Chemotherapy Completed NCT01346267 Phase 3
24 PHASE III STUDY OF ADJUVANT PROCARBAZINE, CCNU AND VINCRISTINE CHEMOTHERAPY IN PATIENTS WITH HIGHLY ANAPLASTIC OLIGODENDROGLIOMA Completed NCT00002840 Phase 3 lomustine;procarbazine hydrochloride;vincristine sulfate
25 Phase III Intergroup Randomized Comparison of Radiation Alone vs. Pre-Radiation Chemotherapy for Pure and Mixed Anaplastic Oligodendrogliomas Completed NCT00002569 Phase 3 lomustine;procarbazine hydrochloride;vincristine sulfate
26 A Phase III Comparison of Hyperfractionated Radiation Therapy (RT) With BCNU and Conventional RT With BCNU for Supratentorial Malignant Glioma Completed NCT03722355 Phase 3 Carmustine
27 PET/CT Imaging of Malignant Glioma With Somatostatin Analog 68Ga-DOTATOC Completed NCT01460706 Phase 2, Phase 3 [68Ga]DOTATOC
28 A Randomized, Double-blind, Placebo-controlled Multi-center Study to Evaluate the Safety and Efficacy of Fentanyl Sublingual Spray (Fentanyl SL Spray) for the Treatment of Breakthrough Cancer Pain Completed NCT00538850 Phase 3 Fentanyl sublingual spray;Placebo
29 A Trial of Dalteparin Low Molecular Weight Heparin for Primary Prophylaxis of Venous Thromboembolism in Brain Tumour Patients (PRODIGE) Completed NCT00135876 Phase 3 dalteparin
30 Clinical Study to Assess the Positive Predictive Value of NPC-07 Induced Tissue Fluorescence in Patients With Malignant Glioma (WHO Grades III/IV) Completed NCT01167322 Phase 3 NPC-07 for oral administration
31 Prospective Randomized Trial of Hypofractionated Radiotherapy Versus Conventional Radiotherapy in Diffuse Brainstem Glioma in Children. Completed NCT01635140 Phase 3
32 A Phase II Study of Observation in Favorable Low-Grade Glioma and a Phase II Study of Radiation With or Without PCV Chemotherapy in Unfavorable Low-Grade Glioma Completed NCT00003375 Phase 2, Phase 3 lomustine;procarbazine hydrochloride;vincristine sulfate
33 Focal Fractionated Conformal Stereotactic Boost Following Conventional Radiotherapy of High Grade Gliomas: A Randomized Phase III Study Completed NCT00003916 Phase 3
34 A Prospective Randomised Trial Comparing Temozolomide With PCV In The Treatment Of Recurrent WHO Astrocytic Tumours Grades III And IV Completed NCT00052455 Phase 3 lomustine;procarbazine hydrochloride;temozolomide;vincristine sulfate
35 Chemotherapy for Progressive Low Grade Astrocytoma in Children Less Than Ten Years Old Completed NCT00002944 Phase 3 carboplatin;lomustine;procarbazine hydrochloride;thioguanine;vincristine sulfate
36 Fluorescence-guided Resection of Malignant Gliomas With 5-Aminolevulinic Acid (5-ALA) vs. Conventional Resection Completed NCT00241670 Phase 3 5-aminolevulinic acid (5-ALA)
37 A Phase III Randomized Trial for the Treatment of Pediatric High Grade Gliomas at First Recurrence With a Single High Dose Chemotherapy and Autologous Stem Cell Transplant Versus Three Courses of Intermediate Dose Chemotherapy With Peripheral Blood Stem Cell (PBSC) Support Completed NCT00078988 Phase 3 carboplatin;etoposide;isotretinoin;thiotepa
38 A Randomized Phase II/III Study of Vorinostat and Local Irradiation OR Temozolomide and Local Irradiation OR Bevacizumab and Local Irradiation Followed by Maintenance Bevacizumab and Temozolomide in Children With Newly Diagnosed High-Grade Gliomas Completed NCT01236560 Phase 2, Phase 3 Temozolomide;Vorinostat
39 Randomized Study of Normal-fractionated Radiotherapy Versus Hypofractionated Radiotherapy Versus Chemotherapy in Patients Over 60 Years With Malignant Glioma Completed NCT00820963 Phase 3 temozolomide
40 NOA-04 Randomized Phase III Study of Sequential Radiochemotherapy of Anaplastic Glioma With PCV or Temozolomide Completed NCT00717210 Phase 3 Temozolomide
41 Phase III Double-blind Placebo-Controlled Trial of Conventional Concurrent Chemoradiation and Adjuvant Temozolomide Plus Bevacizumab Versus Conventional Concurrent Chemoradiation and Adjuvant Temozolomide in Patients With Newly Diagnosed Glioblastoma Completed NCT00884741 Phase 3 Temozolomide
42 PRECISE - Phase III Randomized Evaluation of Convection Enhanced Delivery of IL13-PE38QQR Compared to GLIADEL® Wafer With Survival Endpoint in Glioblastoma Multiforme Patients at First Recurrence Completed NCT00076986 Phase 3 IL13-PE38QQR;prolifespan 20 with carmustine implant (GLIADEL® Wafer)
43 A RANDOMIZED, MULTICENTER, PHASE IIB/IIIA STUDY OF GEMCITABINE AND THE MONOCLONAL ANTIBODY NIMOTUZUMAB (OSAG 101) VERSUS GEMCITABINE AND PLACEBO FOR THE TREATMENT OF CHEMOTHERAPY-NAIVE PATIENTS WITH LOCALLY ADVANCED OR METASTATIC PANCREATIC CANCER Completed NCT00561990 Phase 2, Phase 3 Nimotuzumab
44 Chloroquine as Adjuvant to the Treatment of Glioblastoma Multiforme, A Randomized Trial Completed NCT00224978 Phase 3 Chloroquine
45 Phase III Intergroup Study of Radiotherapy With Concomitant and Adjuvant Temozolomide Versus Radiotherapy With Adjuvant PCV Chemotherapy in Patients With 1p/19q Co-deleted Anaplastic Glioma or Low Grade Glioma Recruiting NCT00887146 Phase 3 concomitant temozolomide (TMZ);procarbazine;adjuvant temozolomide (TMZ);CCNU;vincristine
46 A Study on β-elemene as Maintain Treatment for Complete Remission Patients of Newly Diagnosed Malignant Gliomas Following Standard Treatment Recruiting NCT02629757 Phase 3 β-elemene
47 A Phase III Trial on Adjuvant Standard Temozolomide Chemotherapy With or Without Interferon-alpha in Newly Diagnosed High-grade Gliomas Recruiting NCT01765088 Phase 3 Temozolomide;α-IFN
48 A Randomized Phase 3 Open-Label Study To Evaluate the Efficacy and Safety of Eflornithine With Lomustine Compared to Lomustine Alone in Patients With AA That Progress/Recur After Irradiation and Adjuvant Temozolomide Chemotherapy Recruiting NCT02796261 Phase 3 Eflornithine;Lomustine;Lomustine
49 Efficacy of Post-radiation Adjuvant Temozolomide Chemotherapy in Residue Low-grade Glioma Recruiting NCT01649830 Phase 3 Temozolomide
50 Neuropsychological and Oncological Outcomes in Grade 2 or 3 Glioma Patients Undergoing Postoperative Modern Radiotherapy - A Prospective Follow-up Study Recruiting NCT03534050 Phase 2, Phase 3

Search NIH Clinical Center for Mixed Glioma

Genetic Tests for Mixed Glioma

Anatomical Context for Mixed Glioma

MalaCards organs/tissues related to Mixed Glioma:

41
Brain, T Cells, Testes, Spinal Cord, Bone, Breast, Endothelial

Publications for Mixed Glioma

Articles related to Mixed Glioma:

(show top 50) (show all 300)
# Title Authors PMID Year
1
A PDGFRA promoter polymorphism, which disrupts the binding of ZNF148, is associated with primitive neuroectodermal tumours and ependymomas. 9 38
15635072 2005
2
Tissue culture of human neurocytomas induces the expression of glial fibrilary acidic protein. 9 38
10451427 1998
3
Semiquantitative postembedding characterization of intermediate filaments in central nervous system lesions using immunoelectron microscopy. 9 38
9044656 1995
4
Synchronous identification of a dysembryoplastic neuroepithelial tumor (DNET) and an oligodendroglioma in a patient: A case report. 38
31262396 2019
5
Diagnosing growth in low-grade gliomas with and without longitudinal volume measurements: A retrospective observational study. 38
31136584 2019
6
Concurrent Versus Sequential Chemoradiation for Low-grade Gliomas Meeting RTOG 9802 Criteria. 38
30768441 2019
7
Glioblastoma in the setting of prior lower grade gliomas - insights from SEER database. 38
30279958 2018
8
Reclassification of Mixed Oligoastrocytic Tumors Using a Genetically Integrated Diagnostic Approach. 38
28958143 2018
9
[Adult intramedullary gliomas]. 38
28527519 2017
10
Malignant transformation of low-grade gliomas in patients undergoing adjuvant therapy. 38
27271289 2017
11
Clinicopathological features and microsurgical outcomes for giant pediatric intracranial tumor in 60 consecutive cases. 38
28180935 2017
12
The inhibiting activity of meadowsweet extract on neurocarcinogenesis induced transplacentally in rats by ethylnitrosourea. 38
27838807 2017
13
Proceedings of the 2016 National Toxicology Program Satellite Symposium. 38
27821709 2017
14
Prospective Longitudinal Analysis of 2-Hydroxyglutarate Magnetic Resonance Spectroscopy Identifies Broad Clinical Utility for the Management of Patients With IDH-Mutant Glioma. 38
28248126 2016
15
Unique case of oligoastrocytoma with recurrence and grade progression: Exhibiting differential expression of high mobility group-A1 and human telomerase reverse transcriptase. 38
27672647 2016
16
Morphological Patterns of Intracranial Lesions in a Tertiary Care Hospital in North Karnataka: A Clinicopathological and Immunohistochemical Study. 38
27656442 2016
17
Nogo-A inhibits the migration and invasion of human malignant glioma U87MG cells. 38
27109183 2016
18
Primary Spinal Oligoastrocytoma. 38
27092919 2016
19
Analysis of IDH1-R132 mutation, BRAF V600 mutation and KIAA1549-BRAF fusion transcript status in central nervous system tumors supports pediatric tumor classification. 38
26115961 2016
20
The role of imaging in the management of adults with diffuse low grade glioma: A systematic review and evidence-based clinical practice guideline. 38
26530262 2015
21
Updates in Molecular Pathology of Central Nervous System Gliomas in Adults. 38
26517249 2015
22
Mixed glioma with molecular features of composite oligodendroglioma and astrocytoma: a true "oligoastrocytoma"? 38
25359109 2015
23
Treatment of anaplastic glioma. 38
25468227 2015
24
[Low-grade gliomas in adults]. 38
25391745 2014
25
Mixed Glioma (Oligoastrocytoma) in the brain of an African Hedgehog (Atelerix albiventris). 38
25172052 2014
26
Polysomy of chromosomes 1 and 19: an underestimated prognostic factor in oligodendroglial tumors. 38
25007776 2014
27
Immunohistochemical evaluation of tissue factor, fibrin/fibrinogen and D-dimers in canine gliomas. 38
24745770 2014
28
Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity. 38
23644658 2014
29
Trends in childhood brain tumor incidence, 1973-2009. 38
23925828 2013
30
Analyzing agreement patterns of intraoperative central nervous system lesion reporting according to type and grade. 38
24130410 2013
31
The Evangelismos hospital central nervous system tumor registry: Analysis of 1414 cases (1998-2009). 38
23533006 2013
32
GFAP-positive neoplastic astrocytes in spontaneous oligodendrogliomas and mixed gliomas of rats. 38
23076037 2013
33
Immunohistochemical characterization of spontaneous and acrylonitrile-induced brain tumors in the rat. 38
22821367 2013
34
Molecular genetics of adult grade II gliomas: towards a comprehensive tumor classification system. 38
22890969 2012
35
Clonal analysis in recurrent astrocytic, oligoastrocytic and oligodendroglial tumors implicates IDH1- mutation as common tumor initiating event. 38
22844452 2012
36
Histomolecular classification of adult diffuse gliomas: the diagnostic value of immunohistochemical markers. 38
21889777 2011
37
The effect of WHO reclassification of necrotic anaplastic oligoastrocytomas on incidence and survival in glioblastoma. 38
21229290 2011
38
Glioma Indian scenario: Is there a human leucocyte antigen association? 38
22346237 2011
39
Pleomorphic xanthoastrocytoma and oligodendroglioma: collision of 2 morphologically and genetically distinct anaplastic components. 38
21214337 2011
40
Risk factors for oligodendroglial tumors: a pooled international study. 38
21149253 2011
41
Primary and metastatic intraaxial brain tumors: prospective comparison of multivoxel 2D chemical-shift imaging (CSI) proton MR spectroscopy, perfusion MRI, and histopathological findings in a group of 159 patients. 38
21165751 2011
42
[Beneficial outcomes of an interdisciplinary psychoeducative group intervention for patients with malignant gliomas and their relatives]. 38
21312092 2011
43
Coexistent pathology in chronic epilepsy patients with neoplasms. 38
20495542 2010
44
Persistent outpatient hyperglycemia is independently associated with survival, recurrence and malignant degeneration following surgery for hemispheric low grade gliomas. 38
19589201 2010
45
Clinical features, management and outcomes of high-grade glioma patients in Ramathibodi Hospital. 38
21299082 2010
46
Central nervous system. 38
22112477 2010
47
Tumours arising in the setting of paediatric chronic epilepsy. 38
20632818 2010
48
A retrospective study of primary brain tumors in children under 14 years of age at PIMS, Islamabad. 38
21198267 2010
49
Recurrence and malignant degeneration after resection of adult hemispheric low-grade gliomas. 38
19361270 2010
50
Integrated molecular analysis suggests a three-class model for low-grade gliomas: a proof-of-concept study. 38
19835948 2010

Variations for Mixed Glioma

Expression for Mixed Glioma

Search GEO for disease gene expression data for Mixed Glioma.

Pathways for Mixed Glioma

Pathways related to Mixed Glioma according to GeneCards Suite gene sharing:

# Super pathways Score Top Affiliating Genes
1 10.66 TP53 PDGFRA
2 10.64 TP53 PDGFRA IDH1

GO Terms for Mixed Glioma

Biological processes related to Mixed Glioma according to GeneCards Suite gene sharing:

# Name GO ID Score Top Affiliating Genes
1 female gonad development GO:0008585 8.62 PDGFRA IDH1

Sources for Mixed Glioma

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
17 EFO
18 ExPASy
19 FMA
28 GO
29 GTR
30 HGMD
31 HMDB
32 HPO
33 ICD10
34 ICD10 via Orphanet
35 ICD9CM
36 IUPHAR
37 KEGG
38 LifeMap
40 LOVD
42 MedGen
44 MeSH
45 MESH via Orphanet
46 MGI
49 NCI
50 NCIt
51 NDF-RT
54 NINDS
55 Novoseek
57 OMIM
58 OMIM via Orphanet
62 PubMed
64 QIAGEN
69 SNOMED-CT via HPO
70 TGDB
71 Tocris
72 UMLS
73 UMLS via Orphanet
Content
Loading form....